View Clinical Trial (Medical Research Study)

Comparing The Cyberlink Control System to the Manual Letter Board for Communication Purposes in the ALS Patient Population - NCT00718497-19104(Clinical Trial 231848)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Philadelphia
State:  
PA
Zip Code: 19104
Conditions: Amyotrophic Lateral Sclerosis - Cerebrospinal Fluid - Neurodegenerative Disease - Motor Neuron Disease
Purpose: New technologies are giving people with motor disabilities alternative communication and control channels. The investigators are interested in using the Cyberlink Control System as a hands free means to access a computer for people with Amyotrophic Lateral Sclerosis (ALS). The goal of this project is to determine whether this device is a practical and realistic means for ALS patients to communicate with only the use of facial muscle, brainwave, and eye movements. The benefit of this study may be of substantial value to many people with severe motor impairment. Additionally, it is hoped that some of the study subjects may benefit by incorporating hands-free computer use into their daily lives. This study is intended to evaluate the effectiveness of the cyberlink as a tool for daily communication compared to the standard manual letter board.
Study summary:
Criteria: Inclusion Criteria: - Diagnosis of definite or possible ALS by the El Escorial Criteria - Between ages of 18 to 89 years. - Scored two or less in the ALS FRS category 1 (Speech) - Scored two or less in the ALS FRS category 4 (Handwriting) - Cognitively intact with no other neurological diseases - No unstable medical problems Exclusion Criteria: - Any subject not meeting the inclusion criteria - Patients unable to give informed consent either themselves or via a legally authorized personnel. - Patients diagnosed with neurological problems other than ALS (upon examination by the principal investigator)
Study is available at: MDA/ALS Center of Hope
Philadelphia, PA 19104
United States

Primary Contact:
Christine Barr, RN
Email: cbarr@drexelmed.edu
Phone: 215-762-5186
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 22, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.